Canadian Multicenter Observational Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants

TerminatedOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

November 7, 2012

Primary Completion Date

October 2, 2015

Study Completion Date

October 2, 2015

Conditions
Relapsing-Remitting Multiple Sclerosis
Trial Locations (11)

V8R 1J8

Vancouver Island Health Authority, Victoria

E2L 4L2

Saint John Regional Hospital, Saint John

B3H 4K4

Dalhousie MS Research Unit, Halifax

B1P 1P3

Cape Breton Regional Hospital, Sydney

N6A 5A5

London Health Sciences Centre, London

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

J9J 0A5

Clinique Neuro-Outaouais, Gatineau

J4V 2J2

Neuro Rive-Sud, Greenfield Park

H2L 4M1

CHUM - Hopital Notre Dame, Montreal

H3A 2B4

McGill University - MNI, Montreal

J1H 5N4

CHUS - Hopital Fleurimont, Sherbrooke

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY